Order Article Reprints

Postma M, Fisman D, Giglio N, Márquez-Peláez S, Nguyen VH, Pugliese A, Ruiz-Aragón J, Urueña A, Mould-Quevedo J. Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion. Vaccines. 2023; 11(6):1089. https://doi.org/10.3390/vaccines11061089

Postma, Maarten, David Fisman, Norberto Giglio, Sergio Márquez-Peláez, Van Hung Nguyen, Andrea Pugliese, Jesús Ruiz-Aragón, Analia Urueña, and Joaquin Mould-Quevedo. 2023. "Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion" Vaccines 11, no. 6: 1089. https://doi.org/10.3390/vaccines11061089

Postma, M., Fisman, D., Giglio, N., Márquez-Peláez, S., Nguyen, V. H., Pugliese, A., Ruiz-Aragón, J., Urueña, A., & Mould-Quevedo, J. (2023). Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion. Vaccines, 11(6), 1089. https://doi.org/10.3390/vaccines11061089